Literature DB >> 3770067

Secretion of the gastrokinetic agent cisapride in human milk.

G J Hofmeyr, E W Sonnendecker.   

Abstract

Ten puerperal women were treated with the gastrokinetic agent Cisapride 20 mg 8-h by oral tablets. Breast milk levels of Cisapride had reached a steady state by treatment day 3. Day 4 breast milk levels were 6.2 +/- 1.3 and serum levels 137 +/- 8.1 ng/ml (mean +/- SEM). The breastfeeding infant of a woman on the above treatment would ingest an amount of Cisapride 600-800 times lower than the usual therapeutic dose.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770067     DOI: 10.1007/bf00608226

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

Review 1.  Drugs and pollutants in breast milk.

Authors:  G P Giacoia; C S Catz
Journal:  Clin Perinatol       Date:  1979-03       Impact factor: 3.430

2.  Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol.

Authors:  S Ahlenius; R Brown; J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Domperidone and lactation.

Authors:  G J Hofmeyr; B van Iddekinge
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

4.  Controlled trial of metoclopramide in the initiation of breast feeding.

Authors:  P J Lewis; C Devenish; C Kahn
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

5.  Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: a cross-over study in healthy volunteers.

Authors:  J R Brouwers; J Assies; W M Wiersinga; G Huizing; G N Tytgat
Journal:  Clin Endocrinol (Oxf)       Date:  1980-05       Impact factor: 3.478

6.  Domperidone: secretion in breast milk and effect on puerperal prolactin levels.

Authors:  G J Hofmeyr; B Van Iddekinge; J A Blott
Journal:  Br J Obstet Gynaecol       Date:  1985-02
  6 in total
  5 in total

1.  Secretion of the antidiarrhoeal agent loperamide oxide in breast milk.

Authors:  V C Nikodem; G J Hofmeyr
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

4.  Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.

Authors:  B D Walker; C B Singleton; J A Bursill; K R Wyse; S M Valenzuela; M R Qiu; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.